Dr Reddy's Laboratories Ltd Share Price

Overview

Dr Reddy's Laboratories Ltd share price is currently ₹1,170.33, down by - ₹0.35 (0.03%) from its previous closing price of ₹1,170.68. The share price has gained 1.27% over the past month and declined -5.44% over the past year. The stock's 52-week low and high are ₹0.00 and ₹1,397.94, respectively. Dr Reddy's Laboratories Ltd has a market capitalisation of ₹ 99,960.00 Cr. The share price was last updated on 21 Aug 2026, 12:28 PM IST.

Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd
DRREDDY
 0.00
- 0.35
0.03%
Healthcare
 0.00(%)1D

Updated: 21 Aug 2026, 12:28:45 pm IST

Market Data

Open Price

 1,172.45

Prev. Close

 1,170.68
 1,166.39

Day Low

 1,177.60

Day High

 0.00

52 Week Low

 1,397.94

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

30.33

Sector PE

42.16

PB Ratio

2.59

Sector PB

5.82

EPS

38.59

Dividend Yield

0.64

Today's Volume

536.423 K

5 Day Avg. Volume

1.140 M

PEG Ratio

-1.17

Market Cap.

₹ 99,960.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 800% at ₹8/Share
10-Jul-202610-Jul-2026
DividendsFinal Dividend of 800% at ₹8/Share
10-Jul-202510-Jul-2025
Stock Split1:5
28-Oct-202428-Oct-2024

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
Parag Parikh Flexi Cap Fund - Regular Plan - Growth1.35 Cr
1.43 Cr
(6.28%)
SBI Nifty 50 ETF1.17 Cr
1.18 Cr
(0.72%)
ICICI Prudential Value Fund - Growth94.62 Lac
93.47 Lac
(1.21%)
ICICI Prudential Large Cap Fund - Growth50.90 Lac
56.40 Lac
(10.81%)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth40.15 Lac
50.08 Lac
(24.74%)

About Dr Reddy's Laboratories Ltd 👋

Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

News & Events

Frequently Asked Questions

What is the share price of Dr Reddy's Laboratories Ltd?

What is the market cap of Dr Reddy's Laboratories Ltd?

Should I buy Dr Reddy's Laboratories Ltd stock now?

What is the 52 week high and low of Dr Reddy's Laboratories Ltd?

Is the Dr Reddy's Laboratories Ltd stock good to buy?

Is Dr Reddy's Laboratories Ltd a good buy for the long term?

Is Dr Reddy's Laboratories Ltd overvalued or undervalued?

What is the PE and PB ratio of Dr Reddy's Laboratories Ltd?

Start Now